Abstract: Background: Metabolic dysfunction associated steatotic liver disease (MASLD) is a leading cause of chronic liver disease worldwide and affects >25% in the United States …
Abstract: INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD), an increasing public health concern, remains challenging to diagnose and risk-stratify. We …